Navigation Links
Express Scripts Announces Fourth Quarter 2008 Earnings Conference Call
Date:2/3/2009

ST. LOUIS, Feb. 3 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX), one of the largest pharmacy benefit management companies in North America, announced today its intention to release its fourth quarter earnings on Wednesday, February 25, 2009 after the market closes and will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 26, 2009, at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

This call is being webcast and can be accessed at Express Scripts Web site at www.express-scripts.com

Express Scripts, Inc. is one of the largest PBM companies in North America, providing PBM services to thousands of client groups, including managed-care organizations, insurance carriers, employers, third-party administrators, public sector, workers compensation, and union-sponsored benefit plans.

Express Scripts provides integrated PBM services, including network-pharmacy claims processing, home delivery services, benefit-design consultation, drug-utilization review, formulary management, and medical-and drug-data analysis services. The Company also distributes a full range of biopharmaceutical products directly to patients or their physicians, and provides extensive cost-management and patient-care services.

Express Scripts is headquartered in St. Louis, Missouri. More information can be found at http://www.express-scripts.com, which includes expanded investor information and resources.

    Media Contact
    Jeffrey Hall, Chief Financial Officer
    David Myers, Vice President Investor Relations
    (314) 810-3115
    Investor.relations@express-scripts.com

'/>"/>
SOURCE Express Scripts
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Turning down gene expression promotes nerve cell maintenance
2. Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder
3. Gov. Rendell Expresses Disappointment with Bush Administrations Last-Minute Regulation Limiting Patient Care
4. EMC Receives Express Scripts IT Supplier of the Year Award
5. Tau protein expression predicts breast cancer survival -- though not as expected
6. Expresso Fitness(R) Receives Additional $14 Million in Funding
7. Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines
8. Video: America Votes Crest Whitening Expressions Is FanTaste-ic!
9. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
10. K-State helps nursing home staff become comfortable with residents sexual expression
11. Home Helpers and Veterans Express Helping Spread the Word About Little-Known Veteran's Aid and Attendance Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... (PRWEB) March 06, 2015 Truly Nolen, ... pleased to announce the grand opening of their first ... Charlotte area down to the Fort Mill – Rock ... on February 27th, 2015 at their new location. ... 35 years of collective experience in the pest control ...
(Date:3/6/2015)... Austin, TX (PRWEB) March 06, 2015 ... transformational publishing company, created a unique ‘energy’ experiment ... people’s lives. , After quick ‘5 ... in more than 150+ countries reported their life ... of respondents reported positive results. , According to ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Fluid Running® ... Marathon qualifier, developed the Fluid Running® method ... before the Chicago marathon. She hit upon the trifecta ... group run, and a maximum-resistance, deep water running technique. ... unique no-impact, deep water running workout that made the ...
(Date:3/5/2015)... In 2014, the FDA approved 44 drugs, with ... scoring 4 drug approvals in the USA. The infectious ... drug products, followed by oncology therapy with 18% of ... CDK inhibitors keep on attracting large-cap pharmacos. Nivolumab and ... metastatic melanoma, and at present, they are being investigated ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 AxoGen, ... focused on the peripheral nerve repair market, reported record ... December 31, 2014 compared to $2.98 million in the ... its growth strategies. , “Our strong fourth quarter ... peripheral nerve repair products which is driving increased surgeon ...
Breaking Medicine News(10 mins):Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:250,000+ Person ‘Remote Energy’ Event has 94.2% of Respondents saying “Life Got Better” 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4
... 27 An effective,cross-functional team lays the groundwork ... both initially and long-term. Leading,pharma companies calculate that ... for half of a drug,s success with the,other ... compound, according,to a study by Best Practices, LLC. ...
... The Clinical Trials Directive, which came into force ... harmonised framework for clinical drug research across Europe, ... findings presented at the European Cancer Conference (ECCO ... Hartmann, from European Consulting and Contracting in Oncology, ...
... 27 - Call for international Berthold ... Submissions Applications and proposals are now being ... developers and,researchers who do innovative work in the ... foundation Berthold Leibinger Stiftung is granted for,innovations pertaining ...
... Rendell,recently appointed Richard Snyder, M.D., senior vice president ... the state,s Chronic Care,Commission. Snyder took his oath ... other commission appointees during its first meeting. ... for Pennsylvanians,living with chronic health conditions such as ...
... Spain: In the largest and most rigorous study to ... found that marriages are no more likely than normal ... testicular cancer. , In fact, the study, presented today ... 14) in Barcelona, found most types of cancer resulted ...
... Has Gone Pink To Promote Breast Cancer Awareness, ... entered into,a partnership with Susan G. Komen for the ... with a spreader that features the pink breast,cancer awareness ... of National Breast Cancer Awareness Month and the program ...
Cached Medicine News:Health News:Creating Effective Cross-Functional Teams for Pharmaceutical Commercialization Success 2Health News:Clinical Trials Directive still hampering academic medical research 2Health News:Clinical Trials Directive still hampering academic medical research 3Health News:Prize for Cutting-Edge Laser Innovations 2Health News:Governor Rendell Appoints Dr. Richard Snyder of Independence Blue Cross to Chronic Care Commission 2Health News:Governor Rendell Appoints Dr. Richard Snyder of Independence Blue Cross to Chronic Care Commission 3Health News:Couples more likely to divorce if spouse develops cervical or testicular cancer 2Health News:Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer 2
(Date:3/5/2015)...  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... the approved abbreviated new drug application ("ANDA") for ... previously marketed by Teva Pharmaceuticals.  According to IMS ... approximately $39 million in 2014.   ... of ANI Pharmaceuticals, stated, "This acquisition further expands ...
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4q7gwz/india_pharma ) ... Outlook 2015: Accelerating growth to the next level - ... to their offering. Domestic sales improved ... caused by the market,s reaction to the new drug ... to be healthy, as the momentum continues and improving ...
(Date:3/5/2015)... N.J. , March 5, 2015 Soligenix, ... stage biopharmaceutical company committed to developing products that address ... and biodefense, announced today that its President and Chief ... give a corporate presentation at the 27 th ... , on Tuesday, March 10, 2015 at 1:00 ...
Breaking Medicine Technology:ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 2India Pharma Outlook 2015: Accelerating growth to the next level - Moving up the value chain beyond Generics 3Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
... GHENT, Belgium, December 1, 2011 ... Programs into Clinical Development arGEN-X, a ... human monoclonal antibodies from its proprietary SIMPLE Antibody™ platform, ... (USD 37 million) Series B fundraising round, which was ...
... Nov. 30, 2011  Heart IT, the global leader that ... workstation and Johns Hopkins Medicine, announced the award of ... images in the Nationwide Health Information Network (NHIN). The ... of the National Office of the Coordinator for Health ...
Cached Medicine Technology:arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round 2arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round 3arGEN-X raises EUR 27.5 million (USD 37 million) in oversubscribed Series B Round 4Heart IT and Johns Hopkins Medicine Announce the Award of NIH Grant to Include Images in the Nationwide Health Information Network (NHIN) 2
Tryptone is the pancreatic digest of casein used as a nitrogen source for bacteria. Ideal for general bacteriological use with a variety of microorganisms. Tryptone is guaranteed BSE-Free....
... 10k units Pen.,10k ug Strept. ... Cell Culture Reagent and Buffer ... with cGMP regulations and are ... compatibility. , Typical Properties, Sterility ...
... G) inhibits bacterial growth ... Streptomycin belongs to the ... bacterial growth by inhibiting ... used for prevention and ...
... of Penicillin, Steptomycin, and Amphotericin is ... of cell culture contamination; bacteria (gram ... fungi; when used at a concentration ... is a combination of all three ...
Medicine Products: